Skip to main navigation Skip to search Skip to main content

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

  • The HGSC CRS Collaborative Network (Supplementary 1)
  • , Investigators
  • St John of God Subiaco Hospital
  • University of Western Australia
  • University of Notre Dame Australia
  • Barts Health NHS Trust
  • Vancouver General Hospital
  • King Edward Memorial Hospital for Women
  • Sir Charles Gairdner Hospital
  • Case Western Reserve University
  • Technical University of Munich
  • Leiden University
  • Universidade Federal de São Paulo
  • Birmingham Women's and Children's NHS Foundation Trust
  • University of Glasgow
  • Stanford University
  • Yonsei University
  • Provincial Health Services Authority
  • Queen Mary University of London
  • University College London Hospitals NHS Foundation Trust
  • Royal Devon & Exeter NHS Foundation Trust
  • Belfast Health and Social Care Trust
  • Imperial College London
  • Tata Medical Center
  • Postgraduate Institute of Medical Education and Research
  • Beatson Oncology Centre
  • Canterbury District Health Board
  • National Cancer Center Japan
  • Catholic University of the Sacred Heart
  • St John of God Subiaco Hospital
  • University of Southern Denmark
  • IRCCS
  • Northern Ireland Cancer Centre
  • Department of Gynaecological Oncology

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology